Improved viability of random pattern skin flaps with the use of bone marrow mesenchymal-derived stem cells and chicken embryo extract

Document Type: Original Article

Authors

1 Department of Anatomy, Medical Faculty, Baqyiatallah University of Medical Sciences, Tehran, Iran

2 Department of Physical Therapy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

3 Department of Anatomy, Medical Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Speech Therapy, University of Welfare and Rehabilitation Sciences, Tehran, Iran

5 Department of Biostatistics, Faculty of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Objective(s): Covering tissue defects using skin flaps is a basic surgical strategy for plastic and reconstructive surgery. The aim of this study was to evaluate the effects of chicken embryo extract (CEE) and bone marrow derived mesenchymal stem cells (BM-MSCs) on random skin flap survival (RSF) in rats. Using chicken embryo extract can be an ideal environment for the growth and proliferation of transplanted cells.
Materials and Methods: Forty albino male Wistar rats were divided into 4 groups; each group consisted of 10 rats. BM-MSCs and CEE were transplanted into subcutaneous tissue in the area, where the flap would be examined. On the 7th postoperative day, the survival areas of the flaps were measured by using digital imaging with software assistance, and tissue was collected for evaluation.
Results: Survival area was 19.54±2 in the CEE group and 17.90±2 in the CEE/BM-MSC group when compared to the rates of the total skin flaps, which were significantly higher than the control group (13.47±2) (P<0.05). The biomechanical assessment showed a slight difference, although there was no statistically significant difference between the experimental groups and the control group (P>0.05).
Conclusion: The findings from this study demonstrated that in operative treatment with BM-MSCs and CEE transplantation could promote flap survival, but the biomechanical parameters were not contrasted with a saline injection.

Keywords


1. Harder Y, Amon M, Laschke MW, Schramm R, Rücker M, Wettstein R, et al. An old dream revitalised: preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury. J Plast Reconstr Aesthet Surg 2008; 61:503-511.

2. Siemionow M, Arslan E. Ischemia/reperfusion injury: a review in relation to free tissue transfers". Microsurgery 2004; 24:468-475.

3. Tapuria N, Kumar Y, Habib MM, Amara MA, Seifalian AM, Davidson BR, et al. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury—a review. J Surg Res 2008; 150:304-330.

4. Bauer SM, Goldstein LJ, Bauer RJ, Chen H, Putt M, Velazquez OC. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg 2006; 43:134-141.

5. Wang W Z. Investigation of reperfusion injury and ischemic preconditioning in microsurgery. Microsurgery 2009; 29:72-79.

6. Caiado F, Carvalho T, Silva F, Castro C, Clode N, Dye J, et al. The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing. Biomaterials 2011; 32:7096-7105.

7 .Küntscher MV, Hartmann B, Germann G. Remote ischemic preconditioning of flaps: a review. Microsurgery 2005; 25:346-352.

8. Bayat M, Chelcheraghi F, Piryaei A, Rakhshan M, Mohseniefar Z, Rezaie F, et al. The effect of 30-day pretreatment with pentoxifylline on the survival of arandom skin flap in the rat: An ultrastructural and biomechanical evaluation. Med Sci Monit 2006; 12:BR201-207.

9 .van den Heuvel MG, Buurman WA, Bast A, van der Hulst RR.. Review: ischaemia–reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg 2009; 62:721-726.

10. Singer AJ,Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341:738-746.

11. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000 ; 5:40-46.

12. Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc Med 2001; 11:303-307.

13. Kim JY, Sun HS, Koung LK, Ko JJ, Im JE, Yie SW,  et al. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplant 2010; 19:1635-1644.

14. Barcelos LS, Duplaa C, Kränkel N, Graiani G, Invernici G, Katare R, et al. Human CD133‏ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.  Circ Res 2009; 104:1095-1102.

15. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104:1046-1052.

16. Hiasa KI, Egashira K, Kitamoto S, Ishibashi M, Inoue S, Ni W, et al. Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor. Basic Res Cardiol 2004; 99:165-172.

17. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang Q Y, Lai WH, et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007; 9:747-753.

18. Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res 2009; 335:317-321.

19. Hamou C, Callaghan MJ, Thangarajah H, Chang E, Chang EI, Grogan RH, et al. Mesenchymal stem cells can participate in ischemic neovascularization. Plast Reconstr Surg 2009; 123:45S-55S.

20. Abdollahi H, Harris LJ, Zhang P, McIlhenny S, Srinivas V, Tulenko T, et al. The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res 2011; 165:112-117.

21. Chen L, Tredget EE, Wu PY, Wu Y, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3:e1886.

22. Wang JC, Xia L, Song XB, Wang CE, Wei FC. "Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells improves survival of ultra-long random skin flap. Chin Med J 2011; 124:2507-2511.

23. Zacchigna S, Papa G, Antonini A, Novati F, Moimas S, Carrer A, et al. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am J Pathol 2005; 167:981-991.

24. Zhang F, Waller W, Lineaweaver WC. Growth factors and flap survival. Microsurgery 2004; 24:162-167.

25. Zavan B, Vindigni V, Vezzù K, Zorzato G, Luni C, Abatangelo G, et al. Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study. J Mater Sci Mater Med 2009; 20:235-247.

26. Ichioka S, Kudo S, Shibata M, Ando J, Sekiya N, Nakatsuka T, Bone marrow cell implantation improves flap viability after ischemia-reperfusion injury. Ann Plast Surg 2004; 52:414-418.

27. Lu F, Mizuno H, Uysal CA, Cai X, Ogawa R, Hyakusoku H. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 2008; 121:50-58.

28. Uysal AC, Mizuno H, Tobita M, Ogawa R, Hyakusoku H. The effect of adipose-derived stem cells on ischemia-reperfusion injury: immunohistochemical and ultrastructural evaluation. Plast Reconstr Surg 2009; 124:804-815.

29. Christman SA, Kong BW, Landry MM, Foster DN. Chicken embryo extract mitigates growth and morphological changes in a spontaneously immortalized chicken embryo fibroblast cell line. Poult Sci 2005; 84:1423-1431.

30. Oberley TD, Muth JV, Murphy-Ullrich JE. Growth and maintenance of glomerular cells under defined conditions. Am J Pathol 1980; 101:195-204.

31. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005; 23:1571-1578.

32. Maharlooei MK, Bagheri M, Solhjou Z, Jahromi BM, Akrami M, Rohani L, et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 2011; 93:228-234.

33. Barcelos LS, Duplaa C, Kränkel N, Graiani G, Invernici G, Katare R, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009; 104:1095-1102.

34. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998; 95:3908-3913.

35. Yang M, Sheng L, Li H, Weng R, Li QF. Improvement of the skin flap survival with the bone marrow‐derived mononuclear cells transplantation in a rat model. Microsurgery 2010; 30:275-281.

36. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; A-3B.

37. Ohara H, Kishi K, Nakajima T. Rat dorsal paired island skin flaps: a precise model for flap survival evaluation. Keio J Med 2008; 57:211-216.

 38. Rah DK, Yun IS, Yun CO, Lee SB, Lee WJ. Gene therapy using hepatocyte growth factor expressing adenovirus improves skin flap survival in a rat model. J Korean Med Sci 2014; 29:S228-236.

39. Quirinia A, Viidik A. The effect of hyperbaric oxygen on different phases of healing of ischaemic flap wounds and incisional wounds in skin. Br J Plast Surg 1995; 48:583-589.

40. Quirinia A, Jensen FT, Viidik A. Ischemia in wound healing I: Design of a flap model-changes in blood flow. Scand J Plast Reconstr Surg Hand Surg 1992; 26:21-28.

41. Quirina A. Ischemia in wound Healing II: Design of a flap model—biomechanical properties. Scand J Plast Reconstr Surg Hand Surg 1992; 26:133-139.

42. Morimoto A, Tomita S, Imanishi M, Shioi G, Kihira Y, Izawa-Ishizawa Y, et al. Overexpressed HIF-2α in endothelial cells promotes vascularization and improves random pattern skin flap survival. Plast Reconstr Surg Glob Open 2014; 2:e132.

43. Wang C, Cai Y, Zhang Y, Xiong Z, Li G, Cui L. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression. PLoS One 2014; 9:e100818.

44. Reichenberger MA, Mueller W, Schäfer A, Heimer, S., Leimer, U, Lass, U, et al. Fibrin-embedded adipose derived stem cells enhance skin flap survival. Stem Cell Rev 2012; 8:844-853

45. Richard S, Craft C, McKinney B. Improved survival of ischemic random skin flaps through the use of bone marrow nonhematopoietic stem cells and angiogenic growth factors. Ann Plast Surg 2005; 54:546-552.

46. Khouri RK, Brown DM, Leal-Khouri SM, Tark KC,  Shaw WW. The effect of basic fibroblast growth factor on the neovascularisation process: skin flap survival and staged flap transfers. Br J Plast Surg 1991; 44:585-588.

47. Mogford JE, Tawil B, Jia S, Mustoe TA. Fibrin sealant combined with fibroblasts and platelet‐derived growth factor enhance wound healing in excisional wounds. Wound Repair Regen 2009; 17:405-410.

48. Hu G, Xu JJ, Deng ZH, Feng J, Jin Y. Supernatant of bone marrow mesenchymal stromal cells induces peripheral blood mononuclear cells possessing mesenchymal features. Int J Biol Sci 2011; 7:364-375.

49. Niknejad H, Peirovi H, Ahmadiani A, Ghanavi J, Jorjani M. Differentiation factors that influence neuronal markers expression in vitro from human amniotic epithelial cells. Eur Cell Mater 2010; 19:22-29.

50. Mödder UI, Khosla S. Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment. J Cell Biochem 2008; 103:393-400.

51. Hirschi KK,Goodell MA. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 2002; 9:648-652.

52. Sheng L, Yang M, Li H, Du Z, Yang Y, Li Q. Transplantation of adipose stromal cells promotes neovascularization of random skin flaps. Tohoku J Exp Med 2011; 224:229-234.

53. Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation 2003 25; 108:2613-2618.

54. Michlits W, Mittermayr R, Schäfer R, Redl H, Aharinejad S. Fibrin‐embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair Regen 2007; 15:360-367.

55. Zacchigna S, Papa G, Antonini A, Novati F, Moimas S, Carrer A, et al. Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am J Pathol 2005; 167:981-991.

56. Seify H, Bilkay U, Jones G. Improvement of TRAM flap viability using human VEGF-induced angiogenesis: a comparative study of delay techniques. Plast Reconstr Surg 2003; 112:1032-1039.